Artivion, Inc. (AORT)
Artivion makes medical devices and human tissues for heart and aorta surgery, including stent grafts and heart valves. It last closed at $18.27 on Nov 17, down 1.11% on the day. AORT reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 2 analysts is $36.00 (+97.0% from the last close), with a high of $42.00 and a low of $30.00. In the past 30 days there were 1 dark pool print totaling $621K, the largest $621K.
Key Stats
Last 12 monthsNot reported for this period.
From AORT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 2 analysts who set a price target on AORT in the past 90 days. The average target is $36.00, with a high of $42.00 and a low of $30.00, compared with the last close of $18.27.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 6 | Canaccord Genuity | Target lowered | Buy | $40 → $30 |
| Nov 6 | Citizens | Maintained | Buy | $42 |
| Aug 18 | Canaccord Genuity | Target raised | Buy | $36 → $40 |
| Jul 20 | Needham | Reiterated | Buy | $44 |
| Jun 16 | Canaccord Genuity | Maintained | Buy | $36 |
Technical Analysis
The stock is 21% below its 20 day and 24% below its 50 day average. It is 54% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the 52 week low at $18.11, and the nearest resistance the Pivot at $18.37.
| RSI (14) | 32.32 | Weak, oversold below 30 | Neutral |
| MACD | -1.13 | Below its signal line | Bearish |
| Stochastic | 2.5 | Near the bottom of its range | Oversold |
| ADX (14) | 24.3 | Weak trend | |
| Williams %R | -98.3 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -131.1 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −23.0% | Change over 10 sessions | Bearish |
| ATR (14) | $1.35 | Typical daily range, 7.4% of price |
| RSI (14) | 28.93 | Oversold below 30 | Oversold |
| MACD | -2.64 | Below its signal line | Bearish |
| Stochastic | 2.3 | Near the bottom of its range | Oversold |
| ADX (14) | 25.6 | Trending down | |
| Williams %R | -98.7 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -170.7 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −27.1% | Change over 10 sessions | Bearish |
| ATR (14) | $2.77 | Typical daily range, 15.2% of price |
What happened before
See how AORT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How AORT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in AORT in the last 90 days.
Dark Pool
30DAORT Institutional Ownership
Full report →- ▲126 buying vs 83 selling
- ▲Held by funds +1.1 pts
- ▲Funds holding +10
- ▲Superinvestors: 3 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 216 | 206 | +4.9% |
| In funds' top 10 | 2 | 2 | 0.0% |
| Held by funds | 96.1% | 95.0% | +1.1 pts |
| New / increased | 41 / 85 | 34 / 85 | +5.9% |
| Reduced / sold out | 52 / 31 | 57 / 66 | −32.5% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AORT is in one of them and how their past AORT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered AORT in an article yet. Here's the latest on the wider market.
AORT Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Sell | $1K – $15K | Jul 29, 2026 | Sep 22, 2026 | 55 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Aug 20, 2026 | Sep 11, 2026 | 22 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Jul 16, 2026 | Sep 4, 2026 | 50 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 15, 2026 | Jul 1, 2026 | 47 d |
| Gilbert CisnerosD · CA | Sell (partial) | $1K – $15K | Oct 9, 2025 | Nov 18, 2025 | 40 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Artivion
Artivion is based in Kennesaw, Georgia, and makes medical devices and implantable human tissues for heart and aorta surgery. Its main product lines include aortic stent grafts, On-X mechanical heart valves, surgical sealants such as BioGlue, and processed human heart and vascular tissues. Its products are used mainly by cardiac and vascular surgeons and cardiologists to treat patients with aortic disease, such as heart valve disease and aneurysms. The company sells these products to hospitals and surgical teams around the world.
- Headquarters
- Kennesaw, GA
- Founded
- 1984
- Website
- cryolife.com ↗








